Thierry Levade

16.4k total citations · 1 hit paper
287 papers, 12.2k citations indexed

About

Thierry Levade is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Thierry Levade has authored 287 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Molecular Biology, 120 papers in Physiology and 67 papers in Cell Biology. Recurrent topics in Thierry Levade's work include Sphingolipid Metabolism and Signaling (130 papers), Lysosomal Storage Disorders Research (97 papers) and Lipid Membrane Structure and Behavior (45 papers). Thierry Levade is often cited by papers focused on Sphingolipid Metabolism and Signaling (130 papers), Lysosomal Storage Disorders Research (97 papers) and Lipid Membrane Structure and Behavior (45 papers). Thierry Levade collaborates with scholars based in France, United States and Canada. Thierry Levade's co-authors include Nathalie Andrieu‐Abadie, Robert Salvayre, Jean‐Pierre Jaffrézou, Bruno Ségui, Stéphane Carpentier, Olivier Cuvillier, Patrice Codogno, Anne Nègre‐Salvayre, Virginie Garcia and Guy Laurent and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thierry Levade

284 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

2017 510 citations Jérôme Stirnemann, Roseline Froissart et al. profile →

Peers

Countries citing papers authored by Thierry Levade

Since Specialization

Citations

This map shows the geographic impact of Thierry Levade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Levade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Levade more than expected).

Fields of papers citing papers by Thierry Levade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Levade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Levade. The network helps show where Thierry Levade may publish in the future.

Co-authorship network of co-authors of Thierry Levade

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Levade. A scholar is included among the top collaborators of Thierry Levade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Levade. Thierry Levade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient 2023 ·The CRISPR Journal ·Delphine Leclerc, (unknown), Sylvie Jaillard, (unknown), (unknown), Léna Damaj, Christèle Dubourg, Amandine Etcheverry, Thierry Levade, Roseline Froissart, Stéphane Dréano, X. Guillory, Leif A. Eriksson, Erika Launay, F. Mouriaux, Marc‐Antoine Belaud‐Rotureau, Sylvie Odent, David Gilot	2
2	Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions 2023 ·Biomolecules ·(unknown), (unknown), (unknown), William M. McKillop, Thierry Levade, Jeffrey A. Medin	10
3	Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer 2022 ·Cancers ·(unknown), L. Astudillo, (unknown), (unknown), Magali Pettazzoni, David Cheillan, Jérôme Stirnemann, Thierry Levade, Nathalie Andrieu‐Abadie, Frédérique Sabourdy	2
4	The clinical spectrum of SMA‐PME and in vitro normalization of its cellular ceramide profile 2022 ·Annals of Clinical and Translational Neurology ·Michelle M. Lee, (unknown), Darryl C. De Vivo, Daniel Friedman, Samuel F. Berkovic, (unknown), Argirios Dinopoulos, Katheryn Grand, Pedro A. Sanchez‐Lara, (unknown), Jodi Warman‐Chardon, (unknown), Thierry Levade, Edward H. Schuchman, Steffany A. L. Bennett, David A. Dyment, Toni S. Pearson	5
5	Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease 2021 ·Clinical Genetics ·Dominique P. Germain, Thierry Levade, (unknown), Bertrand Knebelmann, Didier Lacombe, (unknown), Karine Nguyen, Esther Noël, Jean‐Pierre Rabès	46
6	β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 2020 ·Cancer Research ·Mirella Belleri, (unknown), Daniela Coltrini, Roberto Ronca, Daniela Zizioli, Michela Corsini, (unknown), Elisabetta Grillo, Stefano Calza, Roberto Bresciani, Eugenio Maiorano, Mauro G. Mastropasqua, Tiziana Annese, Arianna Giacomini, Doménico Ribatti, Josefina Casas, Thierry Levade, Gemma Fabriàs, Marco Presta	15
7	Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial 2020 ·Clinical Cancer Research ·Anne Montfort, Thomas Filleron, (unknown), (unknown), (unknown), Cécile Pagès, Pascale Olivier, Maha Ayyoub, (unknown), Amélie Lusque, Stéphanie Brayer, Jean‐Pierre Delord, Nathalie Andrieu‐Abadie, Thierry Levade, Céline Colacios, Bruno Ségui, Nicolás Meyer	70
8	Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives 2020 ·Cancers ·Laurence Pellerin, (unknown), (unknown), Laurence Nieto, Bruno Ségui, Thierry Levade, Joëlle Riond, Nathalie Andrieu‐Abadie	46
9	Farber disease: A Fatal Childhood Disorder with Nervous System Involvement 2020 ·Ichraf Kraoua, (unknown), Virginie Garcia, Hanène Benrhouma, (unknown), (unknown), Thierry Levade, (unknown)	1
10	New Insights into the Role of Sphingolipid Metabolism in Melanoma 2020 ·Cells ·(unknown), (unknown), (unknown), Anne Montfort, Thierry Levade, Bruno Ségui, Nathalie Andrieu‐Abadie	21
11	Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas 2018 ·Molecular Cancer Therapeutics ·David Garandeau, (unknown), J. C. Leclerc, Caroline Imbert, Virginie Garcia, Marie‐Lise Bats, Florian Rambow, Julia Gilhodes, Thomas Filleron, Nicolás Meyer, Stéphanie Brayer, (unknown), Sophie Tartare‐Deckert, Bruno Ségui, Jean‐Christophe Marine, Thierry Levade, Corine Bertolotto, Nathalie Andrieu‐Abadie	26
12	Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons 2018 ·Scientific Reports ·(unknown), Ana Paula Terrasso, (unknown), Daniel Simão, Christina Begon‐Pescia, Marina Lavigne, Sara Salinas, Florence Bernex, Assumpció Bosch, Vasiliki Kalatzis, Thierry Levade, Ana María Cuervo, Philippe Lory, Antonella Consiglio, Catarina Brito, Eric J. Kremer	15
13	LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease 2017 ·PLoS ONE ·Magali Pettazzoni, Roseline Froissart, Cécile Pagan, Marie T. Vanier, (unknown), Philippe Latour, Nathalie Guffon, Alain Fouilhoux, (unknown), Thierry Levade, Christine Vianey‐Saban, Monique Piraud, David Cheillan	49
14	Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma 2015 ·Cancer Research ·Florie Bertrand, (unknown), Céline Colacios, Anne Montfort, Anne‐Françoise Tilkin‐Mariamé, Christian Touriol, Philippe Rochaix, Isabelle Lajoie‐Mazenc, Nathalie Andrieu‐Abadie, Thierry Levade, Hervé Benoist, Bruno Ségui	88
15	Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine 2011 ·Journal of Biological Chemistry ·Carmen Bedia, Josefina Casas, Nathalie Andrieu‐Abadie, Gemma Fabriàs, Thierry Levade	69
16	Autologous Transplantation of Lentivector/Acid Ceramidase–Transduced Hematopoietic Cells in Nonhuman Primates 2011 ·Human Gene Therapy ·Jagdeep S. Walia, Anton Neschadim, (unknown), (unknown), Xin Fan, Stéphane Carpentier, Melissa H. Madden, (unknown), Fred Cheung, David A. Jaffray, Thierry Levade, J. Andrea McCart, Jeffrey A. Medin	26
17	Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece 2010 ·American Journal of Medical Genetics Part A ·Bénédicte Héron, Yann Mikaeloff, Roseline Froissart, Guillaume Caridade, Irène Maire, Catherine Caillaud, Thierry Levade, B. Chabrol, François Feillet, Hélène Ogier, Vassili Valayannopoulos, Helen Michelakakis, Dimitrios Zafeiriou, Lawrence A. Lavery, Ed Wraith, Olivier Danos, Jean‐Michel Heard, Marc Tardieu	128
18	Disruption of Sphingosine 1-Phosphate Lyase Confers Resistance to Chemotherapy and Promotes Oncogenesis through Bcl-2/Bcl-xL Upregulation 2009 ·Cancer Research ·Sandra Colié, Paul P. Van Veldhoven, Blandine Kedjouar, Carmen Bedia, (unknown), Sonia‐Caroline Sorli, Virginie Garcia, Mojgan Djavaheri‐Mergny, Chantal Bauvy, Patrice Codogno, Thierry Levade, Nathalie Andrieu‐Abadie	96
19	Danon disease: Further clinical and molecular heterogeneity 2009 ·Muscle & Nerve ·Frédérique Sabourdy, Helen Michelakakis, Aris Anastasakis, Virginie Garcia, Irene Mavridou, (unknown), (unknown), (unknown), Marina Moraitou, Panagiota Manta, M. Elleder, Thierry Levade	11
20	FAN Stimulates TNFα-Induced Gene Expression, Leukocyte Recruitment, and Humoral Response 2009 ·The Journal of Immunology ·Anne Montfort, (unknown), Victorine Douin‐Echinard, Pascal G.P. Martin, Jason S. Iacovoni, (unknown), (unknown), Virginie Garcia, (unknown), Marie-Hélène Bessières, Marie‐Claude Trombe, Thierry Levade, Hervé Benoist, Bruno Ségui	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact